[Featured Stock] Woojeong Bio Shows Early Strength Following COVID-19 Pandemic Declaration

[Asia Economy Reporter Geum Bo-ryeong] The World Health Organization (WHO) declared a pandemic for the novel coronavirus infection (COVID-19) on the 11th (local time), and on the morning of the 12th, Woojung Bio is showing strong performance in the early trading session.

As of 9:13 AM on the day, Woojung Bio's stock price recorded 7,000 KRW, up 6.54% (430 KRW) compared to the previous day.

Woojung Bio, a domestic one-stop solution company specializing in infection control, announced the day before that it had completed the installation of a COVID-19 screening center using the 'drive-through' method at the Gyeonggi Provincial Government Office.

The screening center installed by Woojung Bio this time is a container screening clinic equipped with a negative pressure safety system. This is a case where Woojung Bio applied its know-how, gained from building negative pressure isolation beds in multiple large hospitals, to a container. It is designed as an infection prevention structure that separates the movement paths of the general public and medical staff to protect both patients and healthcare workers.

This content was produced with the assistance of AI translation services.